Related Experiment Videos
A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes
1Department of Community Health Sciences, St George's Hospital Medical School, London, UK. linda.garvican@scn.nhs.uk
Diabetic Medicine : a Journal of the British Diabetic Association
|September 24, 2004
Summary
Pilot study shows quality assurance for diabetic retinopathy screening is challenging due to underfunding and poor data systems. National implementation requires integrated quality assurance from the start.
Area of Science:
- Ophthalmology
- Public Health
- Health Services Research
Background:
- National diabetic retinopathy risk reduction programme development in the UK.
- Quality assurance (QA) recommendations established in 1999.
- Pilot study initiated by existing screening services for QA scheme evaluation.
Purpose of the Study:
- Measure quality assurance targets for diabetic retinopathy screening.
- Compare performance across 10 existing screening services.
- Inform the roll-out of a national screening programme.
Main Methods:
- Developed 17 quality standards in consultation with experts.
- Collected performance data from 10 services for 2001/2.
- Anonymized and centrally analyzed submitted data for comparison.
Main Results:
- All submitted data returns were incomplete, particularly from optometry-based schemes.
- Only five of 17 standards were met by eight or more services.
- Significant challenges included under-funding, limited IT systems, and lack of coordinated management.
Conclusions:
- Quality assurance for diabetic retinopathy screening is resource-intensive and often inadequately funded.
- Pilot study identified key areas for local improvement.
- National programme implementation necessitates integrated QA mechanisms from inception.